Zymogenetics (ZGEN) 9.75 0.00

ZYMOGENETICS
(ZGEN) 9.75 0.00

Last Trade:	9.76	Day Range:	9.76 - 9.76
Trade Time:	Oct 12	52wk Range:	0.00 - 0.00
Prev. Close:	9.76	Market Cap:	838.43M
Open:	9.76	Div Yield:	0
Volume:	0	PE:
EPS:	-0.04

The Latest On ZGEN

Merger Arbitrage Mondays – October 18, 2010 10/18/10 3:02am

Coverage Discontinued On ZymoGenetics 10/14/10 7:32am

Bristol-Myers Squibb Completes Acquisition of ZymoGenetics, Inc. at $9.75 per Share 10/12/10 4:58pm

Bristol Myers at Neutral - Analyst Blog 10/4/10 11:21pm

BMY ZGEN Deal; HSR Period Expires 9/28/10 9:25am

A Peek Into The Market Before The Trading Starts 9/28/10 8:53am

Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of ZymoGenetics 9/28/10 7:38am

Oppenheimer's Current Biotech Ratings 9/13/10 10:41am

Bristol-Myers Squibb Begins Tender Offer to Acquire ZymoGenetics, Inc. (BMY, ZGEN) 9/10/10 7:38am

Zacks Analyst Blog Highlights: Bristol-Myers Squibb, ZymoGenetics, Family Dollar Stores, Wal-Mart Stores and Dollar General Corporation - Press Releases 9/9/10 7:45am

BMY to Acquire ZymoGenetics - Analyst Blog 9/9/10 7:21am

Most Active NASDAQ Stocks Today (ZGEN, INTC, SIRI, JASO, AMAT) 9/8/10 1:03pm

Merger Arbitrage Mondays – October 18, 2010 10/18/10

Coverage Discontinued On ZymoGenetics 10/14/10

Bristol-Myers Squibb Completes Acquisition of ZymoGenetics, Inc. at $9.75 per Share 10/12/10

Bristol Myers at Neutral - Analyst Blog 10/4/10

BMY ZGEN Deal; HSR Period Expires 9/28/10

A Peek Into The Market Before The Trading Starts 9/28/10

Bristol-Myers Squibb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of ZymoGenetics 9/28/10

Oppenheimer's Current Biotech Ratings 9/13/10

Bristol-Myers Squibb Begins Tender Offer to Acquire ZymoGenetics, Inc. (BMY, ZGEN) 9/10/10

Zacks Analyst Blog Highlights: Bristol-Myers Squibb, ZymoGenetics, Family Dollar Stores, Wal-Mart Stores and Dollar General Corporation - Press Releases 9/9/10

BMY to Acquire ZymoGenetics - Analyst Blog 9/9/10

Most Active NASDAQ Stocks Today (ZGEN, INTC, SIRI, JASO, AMAT) 9/8/10

BMY ZGEN Deal; HSR Period Expires 9/28/10

A Peek Into The Market Before The Trading Starts 9/28/10

Mid-Day Market Movers (ZGEN, EDAP, QXM, HDY) 9/8/10

ZymoGenetics Advances On Acquisition News 9/8/10

Benzinga's Top Pre-Market NASDAQ Gainers (ZGEN, TUNE, ARMH, JASO) 9/8/10

Protalix BioTherapeutics And PROLOR Biotech May Rise On "Protein Acquistion" (PBTH, PLX) 9/8/10

Puts Purchased on ZymoGenetics (ZGEN) 8/19/10

Puts Sold on ZymoGenetics (ZGEN) 8/9/10

Puts Purchased on Zymogenetics (ZGEN) 5/27/10

Puts Sold in Zymogenetics 5/11/10

All Signs Bearish for Zymogenetics 5/6/10

Jim Cramer Gives His Opinion On ASIA, ZGEN, WPI, TEVA 4/15/10

Coverage Discontinued On ZymoGenetics 10/14/10

A Peek Into The Market Before The Trading Starts 9/28/10

Oppenheimer's Current Biotech Ratings 9/13/10

BMY to Acquire ZGEN for $9.75/Share 9/8/10

Piper Jaffray Reiterates Neutral Rating on ZymoGenetics (ZGEN) 9/8/10

Trade ZGEN
NOW!

Partner Headlines

Achillion's Pipeline Progresses - Analyst Blog 10/1/10

ZymoGenetics, Mitcham: Volume Movers 9/8/10

Bristol-Myers Pays Up for ZymoGenetics 9/7/10

Javelin Pharmaceuticals, FuelCell Energy: Midday Volume Plays 6/3/10

Press Releases

Get the latest ZGEN stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for ZYMOGENETICS stock price.

ZYMOGENETICS by YCharts

Zymogenetics (ZGEN) 9.75 0.00

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On ZGEN

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social